Fact CheckerSign in

NCT07021144Active, not recruiting

VA|PREVENTION: Randomized Controlled Trial of a Person-Centred Digital Intervention to Prevent Diabetes in High-Risk Adults

Source: ClinicalTrials.gov · Last updated 19 Feb 2026

Brief summary (registry, in English)

The goal of this clinical trial is to help prevent the development of type 2 diabetes (T2D) in adults who are at risk. The study will test a digital intervention called VA\|PREVENTION, a web application designed to support and promote healthy behaviour changes known has T2D risk factors, such as physical activity, diet, and sedentary behaviuor. The main questions this study will explore are:• Is the VA\|PREVENTION web app, which includes a virtual human coach, effective in preventing type 2 diabetes?• Can the VA\|PREVENTION web app be successfully implemented in real-world settings?• Is the VA\|PREVENTION web app cost-effective?• Is it safe for participants to use?To answer these questions, the study team will compare the VA\|PREVENTION web app to an openly available guidebook that provides standard information about preventing type 2 diabetes.Participants will complete the following activities: * Participants will be randomly assigned to one of two groups: one group will use the VA\|PREVENTION app, while the other group will have access to an openly accessible guidebook on T2D prevention. * Participants will be in the study for 10 months. * Participants will be assessed at the start of the study (baseline), and again at 4 months and 10 months. * Assessments will include body measurements (such as weight, height, and waist circumference), physical activity levels, and responses to questionnaires.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
180 (actual)
First submitted
27 May 2025
Start date
3 Jun 2025
Primary completion date
16 Nov 2026
Lead sponsor
Egas Moniz - Cooperativa de Ensino Superior, CRL
NCT number
NCT07021144

What you commit to

  • Study type: Interventional
  • Participants enrolled: 180
  • From 3 Jun 2025 to the primary completion date, 16 Nov 2026
  • 16 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Having undergone bariatric surgery within the past 3 years or planning surgery within the next 10 months;
  • Participating in a concurrent weight management program and/or relevant interventional research protocol;

Other illness

  • Established Type 1 and 2 Diabetes Mellitus diagnosis;
  • Conditions precluding technology use (e.g. cognitive decline, dependent upon a carer for daily activities);
  • Use of anti-obesity or diabetes medication, such as Metformin, Glucagon-like peptide-1 analogue (GLP-1), or other medications known to significantly impact weight (either gain or loss), currently or within the preceding 3 months;
  • Any mental health condition, including, but not limited to, eating disorders or alcohol/substance abuse, that would impact fully participating on the study;
  • Existing thyroid disorder;
  • Active cancer or less than 6 months from treatment;

Other

  • Pregnancy - Self-reported as currently pregnant, planning to become pregnant, or not practicing contraception, in the following 10 months (if applicable);
  • Following a prescribed medical diet;
  • Contraindication to physical activity or weight loss;
  • Unable to provide informed consent or absence of a legal representative that can provided it on behalf of the patient;
  • Institutionalised adults;
  • Foreseeable difficulty in attending study visits.

Who the study is looking for

  • Age ≥ 18 years old;
  • FINDRISC Score ≥12 (moderate, high or very high) and/or prediabetes, defined as either:
    • HbA1c between 5.7%-6.4% within the last two years; or
    • Impaired Glucose Tolerance (IGT) based on an Oral Glucose Tolerance Test (OGTT) at the 120-minute mark, with values between 140 and 199 mg/dL in the past three years;
  • Able to understand, speak and write Portuguese;
  • Able to provide written informed consent;
  • Access to a smartphone, tablet or computer with internet connection;
  • Plan to reside in the recruitment/study area for the next 10 months

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (16)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Farmácia Alvide
Coordinator of this site? Confirm its status
AlcabidechePortugalUnknown status
Farmácia Largo do Coreto
Coordinator of this site? Confirm its status
AlmadaPortugalUnknown status
USF Saúde Laranjeiro
Coordinator of this site? Confirm its status
AlmadaPortugalUnknown status
USF Inovar
Coordinator of this site? Confirm its status
AlmadaPortugalUnknown status
USF Cova da Piedade
Coordinator of this site? Confirm its status
AlmadaPortugalUnknown status
Farmácia da Ramalha
Coordinator of this site? Confirm its status
AlmadaPortugalUnknown status
USF São João do Pragal
Coordinator of this site? Confirm its status
AlmadaPortugalUnknown status
USF Charneca do Sol
Coordinator of this site? Confirm its status
AlmadaPortugalUnknown status
Farmácia Nuno Álvares
Coordinator of this site? Confirm its status
AlmadaPortugalUnknown status
USF Vista Tejo
Coordinator of this site? Confirm its status
AlmadaPortugalUnknown status
Farmácia Romeiro
Coordinator of this site? Confirm its status
AmadoraPortugalUnknown status
Farmácia Santa Marta
Coordinator of this site? Confirm its status
BarreiroPortugalUnknown status
Farmácia Vale Fetal
Coordinator of this site? Confirm its status
CaparicaPortugalUnknown status
USF Costa do Mar
Coordinator of this site? Confirm its status
Costa da CaparicaPortugalUnknown status
Farmácia Quinta da Luz
Coordinator of this site? Confirm its status
LisbonPortugalUnknown status
USF Rosinha
Coordinator of this site? Confirm its status
SeixalPortugalUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.